Journal
CIRCULATION
Volume 141, Issue 22, Pages 1826-1828Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.120.045826
Keywords
Alzheimer disease; atherosclerosis; heart valve diseases; lipoprotein(a); Mendelian randomization analysis; stroke
Funding
- Swedish Heart-Lung Foundation (HjartLungfonden) [20190247]
- Swedish Research Council (Vetenskapsradet) [2019-00977]
- Swedish Research Council for Health, Working Life and Welfare (Forte) [2018-00123]
- Wellcome 4i Clinical PhD Program at Imperial College London
- Sir Henry Dale Fellowship - Wellcome Trust [204623/Z/16/Z]
- Royal Society [204623/Z/16/Z]
- Novartis
- UK Medical Research Council [MR/L003120/1]
- British Heart Foundation [RG/13/13/30194, RG/18/13/33946]
- National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]
- Health Data Research UK - UK Medical Research Council
- Engineering and Physical Sciences Research Council
- Economic and Social Research Council
- Department of Health and Social Care (England)
- Chief Scientist Office of the Scottish Government Health and Social Care Directorates
- Health and Social Care Research and Development Division (Welsh Government)
- Public Health Agency (Northern Ireland)
- British Heart Foundation
- Wellcome
- British Heart Foundation [RG/13/13/30194, RG/18/13/33946] Funding Source: researchfish
- Medical Research Council [MR/L003120/1, HDR-9004] Funding Source: researchfish